|
⚲
|
| Keyboard |
| Shawn Titcomb | |
|---|---|
| Firm | |
| Address | 275 Commercial Blvd, Suite 333 Lauderdale By The Sea, FL 33308 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Praesidia Biotherapeutics Inc | 021-509890 | Director | 7.4 M of 15.0 M |
||
| Praesidia Biotherapeutics Inc | 021-409716 | Director | 4.0 M of 10.0 M |
||
| COYA Therapeutics Inc | 021-385191 | Director | 10.0 M of 10.0 M |
||
| Variant Pharmaceuticals Inc | 021-281680 | Director | 0.5 M of 7.0 M |
||
| Variant Pharmaceuticals Inc | 021-261821 | Director | 1.5 M of 4.0 M |
||
| Variant Pharmaceuticals Inc | 021-255702 | Director | of 25.0 M |
||
| Variant Pharmaceuticals Inc | 021-220851 | Director | 3.0 M of 3.5 M |
||
| Pelican Therapeutics Inc | 021-218767 | Director | 0.2 M of 0.8 M |
||